|
Canadian
Medical Association Journal Home |
Table of Contents Free eCMAJ TOC
Back issues |
Environment and health: 3. Ozone depletion and ultraviolet radiation
Ultraviolet radiation from the sun is responsible for a variety of familiar photochemical reactions, including photochemical smog, bleaching of paints and decay of plastics. Conjugated bonds in organic molecules such as proteins and DNA absorb the UV radiation, which can damage these molecules. By a fortunate evolutionary event, the oxygen produced by photosynthesis forms a filter in the outer reaches of our atmosphere that absorbs the most energetic and harmful UV radiation, with wavelengths below 240 nm (in the UVC band [wavelength 100–280 nm]). In the process, the oxygen molecules split up and recombine to form ozone (Fig. 1). This rarified ozone layer (spread out between 10 and 50 km in the stratosphere but only 3 mm thick were it compressed at ground level) in turn efficiently absorbs UV radiation of higher wavelenghts (up to about 310 nm). A part of the UV radiation in the UVB band (wavelength 280–315 nm) still reaches ground level and is absorbed in sufficient amounts to have deleterious effects on cells. The less energetic radiation in the UVA band (wavelength 315–400 nm, bordering the visible band [wavelength 400–800 nm]) is not absorbed by ozone and reaches ground level without much attenuation through a clear atmosphere (i.e., no clouds, no air polution). Although not completely innocuous, the UVA radiation in sunlight is much less photochemically active and therefore generally less harmful than UVB radiation. Life on earth has adapted itself to the UV stress, particularly UVB stress, for example by forming protective UV-absorbing surface layers, by repairing cell damage or by replacing damaged cells entirely. Human skin shows all of these adaptive features. Our eyes are less well adapted, but they are shielded by the brows and by squinting.
Ozone depletion
In 1974 Molina and Rowland,1 who together with Crutzen received the 1995 Nobel Prize in Chemistry for their work in atmospheric chemistry, proposed that stratospheric ozone might be destroyed by industrially produced chlorine- and bromine-containing stable substances, such as chlorofluorocarbons commonly used in spray cans, refrigerators and air conditioners. These inert substances can reach the stratosphere, where they are decomposed by high-energy UV radiation, and reactive chlorine and bromine are released (Fig. 1).
Although complicated by substantial daily, seasonal and annual fluctuations (in the order of 20%) a gradual downward trend in the amount of stratospheric ozone has been measured in temperate and polar climate zones over the last 2 decades (e.g., 3%–6% per decade at mid-latitudes).2,3 The exceptionally low levels of stratospheric ozone (over 50% depletion) that occur over Antarctica in the early austral spring were unanticipated.4 This ozone "hole" develops because of the generation of reactive chlorine on the surface of ice crystals in high-altitude polar clouds.
The important consequence of a hole in the ozone layer is an increased flux of UV radiation at the earth's surface and in the top layers of the ocean. The productivity of phytoplankton was found to be reduced by 6%–12% directly under the ozone hole.5 Transient effects of increased UV radiation have thus been measured on organisms at the bottom of the marine food chain. What the long-term effects of ozone depletion will be on marine and terrestrial ecosystems is still uncertain.
Health effects
Ozone depletion will not simply increase all UVB-related effects, because adaptive reactions will dampen or even neutralize the impact of an increase in UVB radiation even if sun-exposure behaviour remains the same. For example, the UVB-driven production of vitamin D3 in the skin is self-limiting and the serum level of the ultimately biologically active metabolite (1,25-dihydroxyvitamin D) is controlled by feedback mechanisms that maintain an approximately constant level.6 Therefore, the beneficial effects from vitamin D3 are not expected to be enhanced in a large majority of people: the usual daily sun exposure of head and hands is already sufficient. Among people with regular sun exposure (not sunbathers) rates of sunburn are not likely to increase either, because the human skin can adapt very efficiently to gradual increases in UVB exposure. Photodermatoses may even become less frequent. The loss of adaptation to UV radiation during winter generally increases the incidence and severity of photodermatoses. Because the ozone depletion will be strongest in wintertime, this loss of adaptation will decrease.
The health effects that are believed to be affected by an increased flux in UV radiation include skin cancer, cataract and cellular immunity; the decreased immunity may cause increased severity of infections, less effective vaccinations and perhaps an increase in non-Hodgkin's lymphoma. Skin cancer
UVB radiation is known to damage DNA at specific sites (neighbouring pyrimidines). Mutations in the p53 tumour suppressor gene in human skin carcinomas were found at precisely these sites.7,8 (The p53 protein plays an important role in the cellular response to DNA damage [cell cycle arrest to allow more time for DNA repair, and apoptosis if the cell is overly damaged]. Its dysfunction can cause genomic instability and thus lead to the dysfunction of other genes.) These point mutations in the p53 gene resembled those found in experiments with UV-irradiated cell cultures (mainly a cytosine substituted by a thymine, and sometimes even 2 neighbouring cytosines replaced by 2 thymines).7,8 The high frequency and apparent selection of the p53 mutations in the tumours appears to constitute the most direct evidence that UVB radiation contributes to the formation of skin cancer. The risk of squamous cell carcinoma appears to increase with lifelong sun exposure, whereas accumulated exposure does not appear to contribute to the risk of basal cell carcinoma.9 The risk of basal cell carcinoma10 and cutaneous malignant melanoma11 appears to be related to childhood exposure and to intermittent overexposures. Skin cancer is by far the most common form of cancer among white people in the United States, and the incidence rates of all 3 types of skin cancer increase with increasing ambient UVB radiation loads, although each type of cancer has a different dose–response curve.12,13 Surprisingly, however, experiments in fish14 and opossums15 have indicated that UVA radiation may be more important than UVB radiation in the induction of melanoma.
The effective carcinogenic UV dose of a certain spectrum of sunlight (which varies with solar angle and ozone thickness) can be ascertained by adding up the effective doses contributed by different wavelengths. The wavelength dependence of squamous cell carcinoma induction in humans can be estimated from data obtained in mouse experiments,16,17 and it crudely parallels the wavelength dependence of sunburn (peaking between 290 and 300 nm). Thus, forecasting UV indices to warn against sunburn should help to minimize carcinogenic UV exposures. In general, people need daily exposure to ordinary levels of UVB radiation in order to maintain their vitamin D levels and their adaptation to sun exposure, but overexposure will contribute to adverse effects such as immunosuppression and skin cancer.
The relation between ambient UVB levels and skin cancer incidence rates at different geographic locations can be used to estimate the impact of ozone depletion on skin cancer rates.18 However, it is not well established whether melanoma induction in humans is dominated by UVB radiation; it may be dominated by UVA radiation, as explained earlier. It is therefore uncertain how melanoma will be affected by ozone depletion, which will change only the UVB component of sunlight. Because melanomas constitute a small proportion (< 10%) of skin cancers, they will not greatly affect skin cancer incidence projections. Melanomas are, however, the most lethal type of skin cancer and, if their incidence is not affected by ozone depletion, the projected increases in skin cancer mortality will be overestimated by 25%–50%.
Based on the international agreements to phase out ozone-depleting substances, as described in the Montreal Protocol of 1987 and its later amendments,19 the thickness of the stratospheric ozone layer is expected to reach a minimum around the turn of the century, after which the incidence of skin cancer is projected to reach a maximum (10% higher than current rates) around 2060 and then to fall.18 However, this projection assumes full compliance of all nations and industries with the international agreements. Unrestrained emissions of chlorofluorocarbons and the use of methylbromide in agriculture would be expected to produce a gradual and persistent degradation of the ozone layer and will likely lead to a dramatic increase in skin cancer incidence, which we have estimated could quadruple by the year 2100.18 Cataract The effects of ozone depletion and UV radiation on skin cancer are well studied. Other health effects are less certain, mainly because the wavelength and UV dose dependencies are not adequately established. By assuming that the UVB dominance found in cataract formation in animal experiments also holds for cataract development in humans, we have estimated that the incidence of cataract would ultimately rise by 0.5% for every 1% persistent decrease in ozone.20 Dolin21 reviewed epidemiological studies and concluded that there is good evidence for a relation between (cortical) cataracts and sunlight. Immune effects
Most of the data on immunomodulatory effects of UV radiation stem from mouse experiments, but the suppression of contact hypersensitivity by UV light also occurs in humans, along with many of the cellular effects (disappearance of Langerhans cells, influx of macrophage-like cells and release of certain cytokines such as interleukin-1, tumour necrosis factor
Immunosuppression is a risk factor for both skin cancer and non-Hodgkin's lymphoma. UV-induced immunosuppression might be expected to play a role in the prevalence of these cancers.28 The risk of non-Hodgkin's lymphoma is associated with skin cancer, and the incidence rates of both types of cancer have risen significantly over the past decades. This does not necessarily imply that increased sun exposure is the common causative factor. Unlike skin cancer, non-Hodgkin's lymphoma does not show a clear latitudinal gradient over the United States.29 More recently, however, it has been reported that the incidence of non-Hodgkin's lymphoma in Sweden tends to increase toward the south, but to a considerably lesser extent than that of squamous cell carcinoma.30 Experimental data showed that a combination of a chemical carcinogen and UV exposure induced lymphomas in hairless mice, whereas each agent on its own did not.31 Indirect health effects There is the possibility that human health would not only be directly affected by the increased levels of ambient UVB radiation, but also be indirectly affected by changes to the environment because of stratospheric ozone depletion. For example, UVB radiation contributes to photochemical smog: it can increase ozone at ground level and thus aggrevate respiratory afflictions. A potentially more dramatic effect could stem from a decrease in food production because of the effects of stratospheric ozone depletion on certain plants and animals. These indirect health effects are, however, even less easily quantified than the direct effects on human health.
Conclusion
Overall, compliance with the international agreements on phasing out ozone-depleting substances has been good, but there is no reason for complacency. As the production of the bulk of such substances in developed countries is curbed, other sources become more important. These other sources may prove to be more difficult to phase out; for example, the production and replacement of ozone-depleting substances can be difficult to control in some developing countries because there is no suitable infrastructure or no proper channelling of international support to overcome the locally prohibitive costs for the required changes.2 Moreover, there is always the danger that certain countries that have or have not ratified the agreements will continue to produce or increase production of ozone-depleting substances. To discourage any subversive production of such substances, consumers in developed countries should remain vigilant and not purchase anything operating or produced with ozone-depleting substances when good alternatives are available.
Despite a long-standing concern about the effects of ozone depletion, our understanding of the problem is still incomplete and limited to only a few effects. Our knowledge of the effects of current levels of UV exposure on ecosytems and human health is scanty, which hampers any extrapolation to effects at higher levels of UV exposure. There is an obvious need to remedy the situation, if only to weigh benefits against costs of the next human activity that may threaten the ozone layer. Competing interests: The authors have received speaker fees and travel assistance to attend scientific meetings sponsored by the Dutch Ministry of Housing, Zonal Planning and Environment. Contributors: Dr. de Gruijl wrote the article and Dr. van der Leun contributed to subsequent drafts. Acknowledgements: We thank the Dutch Ministry of Housing, Zonal Planning and Environment for financially supporting our work for the UNEP Panel on the Environmental Effects of an Ozone Depletion. We also thank the European Commission and the Netherlands Cancer Foundation for subsidizing our research.
Additional reading
Related Web sites
Drs. de Gruijl and van der Leun are with the Department of Dermatology, University Hospital of Utrecht/AZU, the Netherlands. This article has been peer reviewed. Series editor: Dr. Michael McCally, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY Reprint requests to: Dr. Frank R. de Gruijl, Department of Dermatology, University Hospital of Utrecht/AZU, PO Box 85500, NL-3508 GA Utrecht, the Netherlands; F.deGruijl@digd.azu.nl
References
Copyright 2000 Canadian Medical Association or its licensors |
and interleukin-10).